About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2011 (2011), Article ID 918707, 13 pages
http://dx.doi.org/10.1155/2011/918707
Review Article

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer

1Department of Pharmaceutical Sciences, Jefferson School of Pharmacy, Thomas Jefferson University, 130 South 9th Street, Edison Building, Suite 1510F, Philadelphia, PA 19107, USA
2Department of Pharmacology and Experimental Therapeutics, University of Maryland and School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201-1559, USA
3Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA

Received 22 June 2011; Accepted 27 July 2011

Academic Editor: Fazlul H. Sarkar

Copyright © 2011 Abhijit M. Godbole and Vincent C. O. Njar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • Puranik Purushottamachar, Abhijit M. Godbole, Lalji K. Gediya, Marlena S. Martin, Tadas S. Vasaitis, Andrew K. Kwegyir-Afful, Senthilmurugan Ramalingam, Zeynep Ates-Alagoz, and Vincent C. O. Njar, “Systematic Structure Modifications of Multitarget Prostate Cancer Drug Candidate Galeterone To Produce Novel Androgen Receptor Down-Regulating Agents as an Approach to Treatment of Advanced Prostate Cancer,” Journal of Medicinal Chemistry, pp. 130607162246006, 2013. View at Publisher ยท View at Google Scholar